Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dipeptidylpeptidase 4 as a Marker of Activated Fibroblasts and a Potential Target for the Treatment of Fibrosis in Systemic Sclerosis
Alina Soare, Hermina A. Györfi, Alexandru‐Emil Matei, et al.
Arthritis & Rheumatology (2019) Vol. 72, Iss. 1, pp. 137-149
Open Access | Times Cited: 104

Showing 1-25 of 104 citing articles:

Origin and functional heterogeneity of fibroblasts
Valerie S. LeBleu, Eric G. Neilson
The FASEB Journal (2020) Vol. 34, Iss. 3, pp. 3519-3536
Open Access | Times Cited: 175
DPP4 inhibition: Preventing SARS‐CoV‐2 infection and/or progression of COVID‐19?
Rocky Strollo, Paolo Pozzilli
Diabetes/Metabolism Research and Reviews (2020) Vol. 36, Iss. 8
Open Access | Times Cited: 103
One year in review 2021: systemic sclerosis
Marco Di Battista, Simone Barsotti, Martina Orlandi, et al.
Clinical and Experimental Rheumatology (2021) Vol. 39, Iss. 4, pp. 3-12
Open Access | Times Cited: 67
SARS-CoV-2 cell entry beyond the ACE2 receptor
Shamila D. Alipoor, Mehdi Mirsaeidi
Molecular Biology Reports (2022) Vol. 49, Iss. 11, pp. 10715-10727
Open Access | Times Cited: 48
Emerging Role of Dipeptidyl Peptidase-4 in Autoimmune Disease
Jie Huang, Xinxin Liu, Yingying Wei, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 40
Attenuation of fibroblast activation and fibrosis by adropin in systemic sclerosis
Minrui Liang, Nicholas Dickel, Andrea‐Hermina Györfi, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 740
Open Access | Times Cited: 12
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
Natasha A. Trzaskalski, Evgenia Fadzeyeva, Erin E. Mulvihill
Clinical Medicine Insights Endocrinology and Diabetes (2020) Vol. 13, pp. 117955142091297-117955142091297
Open Access | Times Cited: 68
Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?
Émile Lévy, Edgard Delvin, Valérie Marcil, et al.
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 4, pp. E689-E708
Open Access | Times Cited: 66
The Roles of Dipeptidyl Peptidase 4 (DPP4) and DPP4 Inhibitors in Different Lung Diseases: New Evidence
Tianli Zhang, Tong Xiang, Shijie Zhang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 49
Non-Epithelial Thymic Stromal Cells: Unsung Heroes in Thymus Organogenesis and T Cell Development
Takeshi Nitta, Hiroshi Takayanagi
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 42
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 31
Functional Roles of CD26/DPP4 in Bleomycin-Induced Pulmonary Hypertension Associated with Interstitial Lung Disease
Tadasu Okaya, Takeshi Kawasaki, Shunichi Sato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 748-748
Open Access | Times Cited: 7
Modelling and targeting mechanical forces in organ fibrosis
Shamik Mascharak, Jason L. Guo, Michelle Griffin, et al.
Nature Reviews Bioengineering (2024) Vol. 2, Iss. 4, pp. 305-323
Closed Access | Times Cited: 7
The role of Dipeptidyl Peptidase‐4 in cutaneous disease
Payal M. Patel, Virginia Jones, Khalaf Kridin, et al.
Experimental Dermatology (2020) Vol. 30, Iss. 3, pp. 304-318
Open Access | Times Cited: 40
Cytokine Storm Modulation in COVID-19: A Proposed Role for Vitamin D and DPP-4 Inhibitor Combination Therapy (VIDPP-4i)
Marcelo Maia Pinheiro, Andrea Fabbri, Marco Infante
Immunotherapy (2021) Vol. 13, Iss. 9, pp. 753-765
Open Access | Times Cited: 38
Dipeptidyl Peptidase-4–Mediated Fibronectin Processing Evokes a Profibrotic Extracellular Matrix
Karina A. Zeyer, Olivier Bornert, Valentin Nelea, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 11, pp. 2477-2487.e13
Open Access | Times Cited: 5
Anatomical location, sex, and age modulate adipocyte progenitor populations in perivascular adipose tissues
C. Javier Rendon, Lorenzo F. Sempere, D. Adam Lauver, et al.
Frontiers in Physiology (2024) Vol. 15
Open Access | Times Cited: 5
Renoprotective Effects of DPP-4 Inhibitors
Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, et al.
Antioxidants (2021) Vol. 10, Iss. 2, pp. 246-246
Open Access | Times Cited: 28
Effect of linagliptin plus insulin in comparison to insulin alone on metabolic control and prognosis in hospitalized patients with SARS-CoV-2 infection
Rodolfo Guardado‐Mendoza, Miguel Angel Garcia-Magaña, Liz Jovanna Martínez-Navarro, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Sex-biased human thymic architecture guides T cell development through spatially defined niches
Laura N Stankiewicz, Kevin Salim, Emily A Flaschner, et al.
Developmental Cell (2024)
Open Access | Times Cited: 4
An Update on Molecular Mechanisms of Scarring—A Narrative Review
Michael Kohlhauser, Marcel Mayrhofer, Lars‐Peter Kamolz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11579-11579
Open Access | Times Cited: 4
PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis
Yun Zhang, Lichong Shen, Honglin Zhu, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 9, pp. 1227-1233
Closed Access | Times Cited: 31
Is DPP4 inhibition a comrade or adversary in COVID-19 infection
Rinkoo Dalan
Diabetes Research and Clinical Practice (2020) Vol. 164, pp. 108216-108216
Open Access | Times Cited: 30
CD26 upregulates proliferation and invasion in keloid fibroblasts through an IGF-1-induced PI3K/AKT/mTOR pathway
Xin Yu, Peiru Min, Heng Xu, et al.
Burns & Trauma (2020) Vol. 8
Open Access | Times Cited: 28
New Insights into Profibrotic Myofibroblast Formation in Systemic Sclerosis: When the Vascular Wall Becomes the Enemy
Eloisa Romano, Irene Rosa, Bianca Saveria Fioretto, et al.
Life (2021) Vol. 11, Iss. 7, pp. 610-610
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top